Thursday, July 27, 2017

GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests

March 4, 2015 by  
Filed under Depression

The combinatorial, multi-gene GeneSight test has been found to better predict antidepressant treatment outcomes for patients with depression, and their use of health care resources, than any of the individual genes that comprise the test, according to a peer-reviewed analysis by investigators from the Mayo Clinic and Assurex Health, and published in today's online edition of The Pharmacogenomics Journal. A retrospective chart review also showed GeneSight results can help predict increased healthcare visits and higher disability claim benefits.

(PRWeb March 03, 2015)

Read the full story at

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!